Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	7	17	9	27	126	171
Market Cap Growth	-33.88%	97.32%	-66.79%	-78.89%	-26.16%	442.34%
Enterprise Value	4	16	15	20	106	113
Last Close Price	1.16	2.92	1.60	13.80	100.20	284.00
PS Ratio	0.09	0.22	0.08	0.28	1.92	6.18
PB Ratio	0.23	0.63	0.23	0.60	0.92	1.80
P/TBV Ratio	-	-	-	-	-	9.45
EV/Sales Ratio	0.05	0.20	0.14	0.21	1.61	4.10
EV/EBITDA Ratio	1.60	2.67	-	-	-	-
Debt / Equity Ratio	0.56	0.59	0.47	0.41	0.18	0.02
Debt / EBITDA Ratio	3.86	1.94	-	-	-	-
Asset Turnover	0.62	0.64	0.78	0.48	0.31	0.29
Inventory Turnover	2.22	2.09	3.57	3.41	2.77	1.45
Quick Ratio	0.72	0.70	0.75	0.64	0.71	1.87
Current Ratio	0.98	1.00	1.03	0.93	0.96	2.62
Return on Equity (ROE)	-22.74%	-47.24%	-40.76%	-119.62%	-50.12%	-26.68%
Return on Assets (ROA)	-2.51%	-1.06%	-5.62%	-11.81%	-11.41%	-11.92%
Return on Capital (ROIC)	-6.26%	-2.65%	-12.81%	-21.18%	-18.43%	-21.52%
Earnings Yield	-73.24%	-90.85%	-192.92%	-408.69%	-46.22%	-7.98%
FCF Yield	7.42%	-7.96%	-58.03%	-108.29%	-22.45%	-16.61%
Buyback Yield / Dilution	-24.72%	-65.81%	-127.22%	-75.54%	-270.57%	-479.80%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q